Hassibian Sepideh, Amin Mahsa, Taghdisi Seyed Mohammad, Sameiyan Elham, Ghaffari Reza, Alibolandi Mona, Ramezani Mohammad, Abnous Khalil, Dehnavi Seyed Mohsen
Department of Cell and Molecular Biology Faculty of Life Science and Biotechnology Shahid Beheshti University Tehran Iran.
Targeted Drug Delivery Research Center Pharmaceutical Technology Institute Mashhad University of Medical Sciences Mashhad Iran.
MedComm (2020). 2025 May 19;6(5):e70180. doi: 10.1002/mco2.70180. eCollection 2025 May.
Single-stranded DNA or RNA entities referred to as aptamers exhibit a strong affinity and specificity for attaching to specific targets. Owing to their special properties, which include simplicity of synthesis, low immunogenicity, and adaptability in targeting a variety of substances, these synthetic oligonucleotides have garnered a lot of interest. The function of aptamers can be altered by combining them with complementary oligonucleotides "antidotes," which are antisense to a particular aptamer sequence. Antidotes play an important role in several fields by specifically targeting the corresponding section of the aptamer. Nevertheless, even with their promising capabilities, the creation of antidotes to regulate or inhibit aptamer function continues to be a relatively unexamined field, constraining their secure and efficient application in medical environments. The review explores experimental methodologies for creating antidotes, the systematic design strategies for managing antidotes in aptamer-based therapies, and their therapeutic efficacy in counteracting disease biomarkers. Additionally, it highlights their diagnostic applications in biosensing and imaging, offering a promising alternative to traditional antibodies. It also investigates the progress, latest innovations, and potential medical uses of aptamer-antidote combinations. Its academic value lies in bridging the gap between theoretical design and practical applications, providing researchers and clinicians with a comprehensive resource to advance aptamer-based solutions in medicine and biotechnology.
被称为适体的单链DNA或RNA实体对附着特定靶标表现出很强的亲和力和特异性。由于其特殊性质,包括合成简单、免疫原性低以及能够靶向多种物质,这些合成寡核苷酸引起了广泛关注。通过将适体与互补寡核苷酸“解毒剂”结合,可以改变适体的功能,这种解毒剂与特定适体序列呈反义关系。解毒剂通过特异性靶向适体的相应部分,在多个领域发挥重要作用。然而,尽管它们具有令人期待的能力,但开发用于调节或抑制适体功能的解毒剂仍然是一个相对未被充分研究的领域,这限制了它们在医疗环境中的安全有效应用。本综述探讨了制备解毒剂的实验方法、基于适体疗法中管理解毒剂的系统设计策略,以及它们在对抗疾病生物标志物方面的治疗效果。此外,还强调了它们在生物传感和成像中的诊断应用,为传统抗体提供了一种有前景的替代方案。同时研究了适体 - 解毒剂组合的进展、最新创新以及潜在的医学用途。其学术价值在于弥合理论设计与实际应用之间的差距,为研究人员和临床医生提供全面的资源,以推动医学和生物技术中基于适体的解决方案的发展。